Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
CAH
Deeply undervalued
CARDINAL HEALTH INC
Price$238.96
Model IV$422.73
P/IV0.53
Discount 43%
Return to IV: +76.9%
Market implies -1.1%/yr
vs model +7.7% · below model
COR
Undervalued
Cencora, Inc.
Price$321.35
Model IV$407.09
P/IV0.78
Discount 21%
Return to IV: +26.7%
Market implies +4.2%/yr
vs model +9.0% · below model
COSM
Valuation N/A
Cosmos Health Inc.
Price$0.31
Model IV—
P/IV—
Market implies +12.5%/yr
HKPD
Valuation N/A
Cellyan Biotechnology Co., Ltd
Price$0.10
Model IV—
P/IV—
Market implies -25.0%/yr
vs model +11.7% · below model
HLF
Deeply undervalued
HERBALIFE LTD.
Price$12.82
Model IV$22.26
P/IV0.43
Discount 42%
Return to IV: +73.7%
Market implies -6.6%/yr
vs model +3.1% · below model
HWH
Valuation N/A
HWH International Inc.
Price$2.57
Model IV—
P/IV—
Market implies +18.2%/yr
vs model +15.0% · above model
MCK
Undervalued
MCKESSON CORP
Price$930.25
Model IV$1,290.14
P/IV0.69
Discount 28%
Return to IV: +38.7%
Market implies +3.3%/yr
vs model +9.3% · below model
NUS
Deeply undervalued
NU SKIN ENTERPRISES, INC.
Price$4.77
Model IV$7.87
P/IV0.59
Discount 39%
Return to IV: +65.0%
Market implies -8.3%/yr
vs model +2.0% · below model
WGRX
Valuation N/A
Wellgistics Health, Inc.
Price$3.03
Model IV—
P/IV—
Market implies +81.3%/yr
vs model +15.0% · above model